Overview

Impact of Acetaminophen on Postoperative Delirium Elderly Patients After Non-cardiac Surgery

Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
0
Participant gender:
All
Summary
To investigate the impact of acetaminophen analgesia on the frequency of postoperative delirium and 28 days mortality in elderly patients after noncardiac surgery.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Xiangya Hospital of Central South University
Collaborator:
Yale University
Treatments:
Acetaminophen
Sufentanil
Criteria
Inclusion Criteria:

1. Scheduled to ICU after non-cardiac surgery for any reasons;

2. Report having moderate to severe acute pain as determined by a pain score ≥ 5 from the
11-point Numeric Pain Rating Scale (NPRS) scale after postsurgery;

3. Able to take oral medication or by stomach tube;

4. Provide written informed consent.

Exclusion Criteria:

- Patients who meet any of the following criteria will be excluded.

1. Preoperative history of schizophrenia, epilepsy, Parkinsonism, or myasthenia
gravis;

2. Inability to communicate in the preoperative period because of coma, profound
dementia or language barrier;

3. Brain injury or neurosurgery;

4. Severe hepatic dysfunction (eg, aspartate aminotransferase, alanine
aminotransferase, or bilirubin greater than or equal to 3.0 times the upper limit
of normal), active hepatic disease, evidence of clinically significant liver
disease, or other condition (eg, alcoholism, cirrhosis, or hepatitis) that
suggests the potential for an increased susceptibility to hepatic toxicity with
study drug exposure.

5. Subject has a positive test result for drugs of abuse (amphetamines,
barbiturates, benzodiazepines, cannabinoids, cocaine, methamphetamine, methadone,
or methylenedioxy-methamphetamine) at Screening.

6. Subject has participated in another clinical study within 30 days prior to
day-of-surgery or plans to participate in another clinical study while
concurrently enrolled in this study.

7. Subject has a history of any drug allergy, hypersensitivity, or intolerance to
acetaminophen or morphine or to any of the excipients in the IV or oral
formulations used.

8. Subject has intra- or postoperative complications, which in the view of the
investigator, makes the subject unsuitable for the participation of the study.

9. Subject has a history of any drug allergy, hypersensitivity, or intolerance to
acetaminophen or opioid or to any of the excipients in the IV or oral
formulations used.

10. Unable to take medications orally or by stomach tube